Authors: Rosenkilde, MM Waldhoer, M Luttichau, HR Schwartz, TW

Citation: Mm. Rosenkilde et al., Virally encoded 7TM receptors, ONCOGENE, 20(13), 2001, pp. 1582-1593

Authors: Rosenkilde, MM Schwartz, TW

Citation: Mm. Rosenkilde et Tw. Schwartz, Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor, MOLEC PHARM, 57(3), 2000, pp. 602-609

Authors: Rosenkilde, MM Kledal, TN Holst, PJ Schwartz, TW

Citation: Mm. Rosenkilde et al., Selective elimination of high constitutive activity or chemokine binding in the human herpesvirus 8 encoded seven transmembrane oncogene ORF74, J BIOL CHEM, 275(34), 2000, pp. 26309-26315

Authors: Klasse, PJ Rosenkilde, MM Signoret, N Pelchen-Matthews, A Schwartz, TW Marsh, M

Citation: Pj. Klasse et al., CD4-chemokine receptor hybrids in human immunodeficiency virus type 1 infection, J VIROLOGY, 73(9), 1999, pp. 7453-7466

Authors: Rosenkilde, MM Kledal, TN Brauner-Osborne, H Schwartz, TW

Citation: Mm. Rosenkilde et al., Agonists and inverse agonists for the herpesvirus 8-encoded constitutivelyactive seven-transmembrane oncogene product, ORF-74, J BIOL CHEM, 274(2), 1999, pp. 956-961

Authors: Kledal, TN Rosenkilde, MM Schwartz, TW

Citation: Tn. Kledal et al., Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28, FEBS LETTER, 441(2), 1998, pp. 209-214